Skip to main content
main-content

Zeitschrift

Clinical and Translational Oncology

Clinical and Translational Oncology 2/2018

Ausgabe 2/2018

Inhaltsverzeichnis ( 15 Artikel )

13.06.2017 | Review Article | Ausgabe 2/2018

Management of unresectable, locally advanced pancreatic adenocarcinoma

M. Salgado, S. Arévalo, O. Hernando, A. Martínez, R. Yaya, M. Hidalgo

07.06.2017 | Review Article | Ausgabe 2/2018

Key points to optimizing management and research on cancer-associated thrombosis

A. Carmona-Bayonas, M. Sánchez-Cánovas, J. M. Plasencia, A. Custodio, E. Martínez de Castro, J. A. Virizuela, F. Ayala de la Peña, P. Jiménez-Fonseca

16.06.2017 | Review Article | Ausgabe 2/2018

The potential roles of bacteria to improve radiation treatment outcome

E. Kouhsari, A. Ghadimi-Daresajini, H. Abdollahi, N. Amirmozafari, S. R. Mahdavi, S. Abbasian, S. H. Mousavi, H. F. Yaseri, M. Moghaderi

19.06.2017 | Research Article | Ausgabe 2/2018

Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors

F. Koinis, A. Voutsina, A. Kalikaki, A. Koutsopoulos, E. Lagoudaki, E. Tsakalaki, E. K. Dermitzaki, E. Kontopodis, A. G. Pallis, V. Georgoulias, A. Kotsakis

14.06.2017 | Research Article | Ausgabe 2/2018

Quality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trial

L. Kepka, D. Tyc-Szczepaniak, K. Osowiecka, A. Sprawka, B. Trąbska-Kluch, B. Czeremszynska

13.06.2017 | Research Article | Ausgabe 2/2018

MRI-guided radiotherapy for head and neck cancer: initial clinical experience

A. M. Chen, S. Hsu, J. Lamb, Y. Yang, N. Agazaryan, M. L. Steinberg, D. A. Low, M. Cao

03.07.2017 | Research Article | Ausgabe 2/2018 Open Access

Characteristics of adverse drug reactions in a vemurafenib early post-marketing phase vigilance study in Japan

H. Uhara, Y. Kiyohara, A. Tsuda, M. Takata, N. Yamazaki

14.07.2017 | Research Article | Ausgabe 2/2018

Clinicopathologic parameters associated with postoperative complications and risk factors for tumor recurrence and mortality after tumor resection of patients with colorectal cancer

Z. Bai, J. Wang, T. Wang, Y. Li, X. Zhao, G. Wu, Y. Yang, W. Deng, Z. Zhang

30.06.2017 | Research Article | Ausgabe 2/2018

Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database

A. Hervás, A. Gómez-Caamaño, M. Casaña, A. Gómez-Iturriaga, J. Pastor, J. Jove, J. L. Mengual, C. Gónzalez-San Segundo, J. Muñoz

17.07.2017 | Research Article | Ausgabe 2/2018

Cancer survival in adult patients in Spain. Results from nine population-based cancer registries

M. D. Chirlaque, D. Salmerón, J. Galceran, A. Ameijide, A. Mateos, A. Torrella, R. Jiménez, N. Larrañaga, R. Marcos-Gragera, E. Ardanaz, M. Sant, P. Minicozzi, C. Navarro, M. J. Sánchez, the REDECAN Working Group

05.07.2017 | Research Article | Ausgabe 2/2018

An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis

Y. Wang, L. He, Y. Cheng

13.07.2017 | Research Article | Ausgabe 2/2018

Treatment strategies for rectal cancer with synchronous liver metastases: surgical and oncological outcomes with propensity-score analysis

H. Salvador-Rosés, S. López-Ben, P. Planellas, E. Canals, M. Casellas-Robert, R. Farrés, E. Ramos, A. Codina-Cazador, J. Figueras

10.07.2017 | Research Article | Ausgabe 2/2018

The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism

P. Jiménez-Fonseca, A. Carmona-Bayonas, C. Font, J. Plasencia-Martínez, D. Calvo-Temprano, R. Otero, C. Beato, M. Biosca, M. Sánchez, M. Benegas, D. Varona, L. Faez, M. Antonio, I. de la Haba, O. Madridano, M. P. Solis, A. Ramchandani, E. Castañón, P. J. Marchena, M. Martín, F. Ayala de la Peña, V. Vicente, On behalf of the EPIPHANY study investigators and the Asociación de Investigación de la Enfermedad Tromboembólica de la Región de Murcia

12.07.2017 | Research Article | Ausgabe 2/2018 Open Access

Bevacizumab plus chemotherapy for patients with advanced pulmonary adenocarcinoma harboring EGFR mutations

R.-L. Chen, H.-J. Chen, B.-Y. Jiang, X.-C. Zhang, Q. Zhou, H.-Y. Tu, W.-Z. Zhong, Y.-L. Wu, J.-J. Yang

26.06.2017 | Brief Research Article | Ausgabe 2/2018

Histopathological factors predicting response to neoadjuvant therapy in gastric carcinoma

M. L. Sánchez de Molina, C. Díaz del Arco, P. Vorwald, D. García-Olmo, L. Estrada, M. J. Fernández-Aceñero

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise